Advances in gene-editing technology enable efficient, targeted ex vivo engineering of different cell types, which offer a potential therapeutic platform for most challenging disease areas. CRISPR ...

Researchers from Broad Institute and Harvard University presented the discovery of all-in-one virus-like particles (VLPs) designed to deliver prime editor (PE) ribonucleoprotein (RNP) complexes into ...

Please provide your email address to receive an email when new articles are posted on . A possible genetic rationale for why women acquire more autoimmune diseases than men has been discovered, ...